Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy - Concepedia

Concepedia

Publication | Closed Access

Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy

40

Citations

30

References

2020

Year

Parvin Zamani, Jamshid Gholizadeh Navashenaq, Manouchehr Teymouri, Maryam Karimi, Mohammad Mashreghi, Mahmoud Reza Jaafari

Liposomal VaccineImmunologyTumor ImmunityTherapeutic VaccineLiposomal DoxorubicinImmunotherapeuticsCombination TherapyImmunotherapyMedicineRadiation OncologySynthetic Immunology

References

	Year	Citations

Page 1